Ether

Ether

SCHEMBL2146705

CC(=O)OC(C)C.CCOCC

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.70
ALDH1A1 P00352 3/20 0.44
LMNA P02545 3/20 0.42
HSD17B10 Q99714 1/20 0.42
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
TBXA2R P21731 1/20 0.41
GALR3 O60755 1/20 0.40
MAPT P10636 1/20 0.40
BLM P54132 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.34
THRB P10828 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
HCAR2 Q8TDS4 1/20 0.33
ALOX15 P16050 1/20 0.33
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
HRH1 P35367 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL330790 0.93 TSHR (0.61) TSHRALDH1A1LMNAHSD17B10CHRM2
Propylene Glycol SCHEMBL329889 0.89 TSHR (0.56) TSHRALDH1A1LMNAHSD17B10CHRM2
Di(Hydroxyethyl)Ether SCHEMBL597204 0.88 TSHR (0.54) TSHRALDH1A1LMNAHSD17B10CHRM2
Propane SCHEMBL27531646 0.87 TSHR (0.82) TSHRALDH1A1LMNAHSD17B10CHRM2
Triethylene Glycol SCHEMBL596542 0.86 TSHR (0.52) TSHRALDH1A1LMNAHSD17B10CHRM2
2-Ethoxyethanol SCHEMBL125169 0.85 TSHR (0.56) TSHRALDH1A1LMNAHSD17B10CHRM2
Ether SCHEMBL3257210 0.84 TSHR (0.50) TSHRALDH1A1LMNAHSD17B10CHRM2
Alcohol SCHEMBL247964 0.84 TSHR (0.78) TSHRALDH1A1LMNAHSD17B10CHRM2
SCHEMBL21064874 0.84 TSHR (1.00) TSHRALDH1A1LMNACHRM2CHRM4
SCHEMBL19193 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12023409-B2 Phosphodiesterase-4 inhibitor combinations, methods of making, and methods of use thereof VK RESEARCH ASSOCIATES INC. (US) 2024-07-02 US disclosed
US-20230043979-A1 PHOSPHODIESTERASE-4 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF VK Research Associates Inc 2023-02-09 US disclosed
CN-114891366-A Colorant, colored resin composition comprising the same, and color filter 乐金显示有限公司 2022-08-12 CN disclosed
CN-114341232-A Method for producing silicon-containing polymer composition 日产化学株式会社 2022-04-12 CN disclosed
CN-113439223-A Optical filter for solid-state imaging element and solid-state imaging element 凸版印刷株式会社 2021-09-24 CN disclosed
US-20210275531-A1 PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF VK Research Associates Inc 2021-09-09 US disclosed
US-10426724-B2 Antihistamine compositions, combinations, and use thereof APTAPHARMA INC. (US) 2019-10-01 US disclosed
US-20180338913-A1 ANTIHISTAMINE COMPOSITIONS, COMBINATIONS, AND USE THEREOF APTAPHARMA INC (US) 2018-11-29 US disclosed
US-10064820-B2 Antihistamine compositions, combinations, and use thereof APTAPHARMA INC. (US) 2018-09-04 US disclosed
US-20180092837-A1 ANTIHISTAMINE COMPOSITIONS, COMBINATIONS, AND USE THEREOF APTAPHARMA INC. 2018-04-05 US disclosed
US-8497290-B2 Thiocolchicine derivatives, method of making and methods of use thereof TAKEDA PHARMACEUTICALS U.S.A., INC. (US) 2013-07-30 US disclosed
US-20130053399-A1 METHODS OF ADMINISTERING ANTIHISTAMINES APTAPHARMA INC. 2013-02-28 US disclosed
CN-102448930-A Thiocolchicine derivatives, method of making and methods of use thereof MUTUAL PHARMACEUTICAL CO 2012-05-09 CN disclosed
US-20110184061-A1 THIOCOLCHICINE AND COLCHICINE ANALOGS, METHODS OF MAKING AND METHODS OF USE THEREOF MPC OLDCO, INC. 2011-07-28 US disclosed
WO-2011091114-A2 THIOCOLCHICINE AND COLCHICINE ANALOGS, METHODS OF MAKING AND METHODS OF USE THEREOF MUTUAL PHARMACEUTICAL COMPANY, INC. (US) 2011-07-28 WO disclosed
US-20110178180-A1 DEUTERIUM-ENRICHED COLCHICINE, THIOCOLCHICINE, AND DERIVATIVES THEREOF; METHODS OF PREPARATION; AND USE THEREOF MPC OLDCO, INC. 2011-07-21 US disclosed
WO-2010138670-A2 THIOCOLCHICINE DERIVATIVES, METHOD OF MAKING AND METHODS OF USE THEREOF MUTUAL PHARMACEUTICAL COMPANY, INC. (US) 2010-12-02 WO disclosed
US-20100305165-A1 THIOCOLCHICINE DERIVATIVES, METHOD OF MAKING AND METHODS OF USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-02 US disclosed
EP-0804865-A1 PRODUCTION OF ELECTRICAL CIRCUIT BOARDS Coates Brothers PLC (GB) 1997-11-05 EP disclosed
WO-1996022670-A1 PRODUCTION OF ELECTRICAL CIRCUIT BOARDS COATES BROTHERS PLC (GB) 1996-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178180-A1 DEUTERIUM-ENRICHED COLCHICINE, THIOCOLCHICINE, AND DERIVATIVES THEREOF; METHODS OF PREPARATION; AND USE THEREOF MTPN, TNNC1, PDF TSHR 2035/4885ALDH1A1 4483/4885LMNA 905/4885
US-20100305165-A1 THIOCOLCHICINE DERIVATIVES, METHOD OF MAKING AND METHODS OF USE THEREOF TNNC1, TNNI3, TNNT2 TSHR 1049/4885ALDH1A1 1790/4885LMNA 1706/4885
US-20110184061-A1 THIOCOLCHICINE AND COLCHICINE ANALOGS, METHODS OF MAKING AND METHODS OF USE THEREOF TPMT, TNNC1, MTPN TSHR 2212/4885ALDH1A1 3416/4885LMNA 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.